Global, regional, and national burden of severe periodontitis, 1990–2019: an analysis of the Global Burden of Disease Study 2019

Author(s):  
Meng Xuan Chen ◽  
Yu Jie Zhong ◽  
Qian Qian Dong ◽  
Hai Ming Wong ◽  
Yi Feng Wen
2021 ◽  
Vol 2 ◽  
pp. 12-18
Author(s):  
Katelyn Urban ◽  
Sherman Chu ◽  
Rachel L. Giesey ◽  
Sino Mehrmal ◽  
Prabhdeep Uppal ◽  
...  

The Lancet ◽  
2020 ◽  
Vol 395 (10225) ◽  
pp. 709-733 ◽  
Author(s):  
Boris Bikbov ◽  
Caroline A Purcell ◽  
Andrew S Levey ◽  
Mari Smith ◽  
Amir Abdoli ◽  
...  

Rheumatology ◽  
2020 ◽  
Author(s):  
Saeid Safiri ◽  
Ali Asghar Kolahi ◽  
Marita Cross ◽  
Kristin Carson-Chahhoud ◽  
Amir Almasi-Hashiani ◽  
...  

Abstract Objectives To describe the level and trends of point prevalence, deaths and disability-adjusted life years (DALYs) for other musculoskeletal (MSK) disorders, i.e. those not covered by specific estimates generated for RA, OA, low back pain, neck pain and gout, from 1990 to 2017 by age, sex and sociodemographic index. Methods Publicly available modelled estimates from the Global Burden of Disease (GBD) 2017 study were extracted and reported as counts and age-standardized rates per 100 000 population for 195 countries and territories between 1990 and 2017. Results Globally, the age-standardized point prevalence estimates and deaths rates of other MSK disorders in 2017 were 4151.1 and 1.0 per 100 000. This was an increase of 3.4% and 7.2%, respectively. The age-standardized DALY rate in 2017 was 380.2, an increase of 3.4%. The point prevalence estimate was higher among females and increased with age. This peaked in the 65–69 year age group for both females and males in 2017, followed by a decreasing trend for both sexes. At the national level, the highest age-standardized point prevalence estimates in 2017 were seen in Bangladesh, India and Nepal. The largest increases in age-standardized point prevalence estimates were observed in Romania, Croatia and Armenia. Conclusion The burden of other MSK disorders is proven to be substantial and increasing worldwide, with a notable intercountry variation. Data pertaining to specific diseases within this overarching category are required for future GBD MSK estimates. This would enable policymakers to better allocate resources and provide interventions appropriately.


2017 ◽  
Vol 16 (11) ◽  
pp. 877-897 ◽  
Author(s):  
Valery L Feigin ◽  
Amanuel Alemu Abajobir ◽  
Kalkidan Hassen Abate ◽  
Foad Abd-Allah ◽  
Abdishakur M Abdulle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document